Funding for ordering period one of 36C25526A0007
Active Awarded Last action
- Contract number
- 36C25526N0058
- Awardee
-
Progenics Pharmaceuticals Inc. UEI YLYKVRPCTCR3 Part of Lantheus Holdings, Inc.
- Awarding agency
-
Veterans Integrated Service Network 15
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $396,959
Award facts
- Contract value 100% obligated
- $396,959.20 Current and potential, with all options
- Completion date 49% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- North Billerica, Billerica, MA 01862, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 15 (VISN 15), awarded a Blanket Purchase Agreement (BPA) call to Progenics Pharmaceuticals Inc., a division of Lantheus Medical Imaging, Inc., for ordering period one with a ceiling value of $396,959.20. This firm fixed-price contract was awarded on November 1, 2025, with an ultimate completion date of October 31, 2027. The award is not set-aside and will be performed in North Billerica, Massachusetts. This contract call represents an order against an existing BPA vehicle (36C25526A0007) through which the VA procures critical radiopharmaceutical products, particularly diagnostic imaging agents used in medical imaging programs across VA medical facilities.
Progenics Pharmaceuticals specializes in supplying innovative diagnostic imaging agents, including PYLARIFY (piflufolastat F-18), a radioactive diagnostic agent used in positron emission tomography (PET) scans for prostate cancer detection and localization. The company maintains several significant indefinite delivery vehicles with the VA and Defense Health Agency with ceiling values ranging up to $290 million, facilitating efficient procurement of radiopharmaceuticals and related nuclear medicine supplies. This particular BPA call supports the VA's medical imaging programs by providing access to specialized radiopharmaceutical products needed across multiple VA medical centers and healthcare facilities nationwide.
Quick answers
Who was awarded contract 36C25526N0058?
36C25526N0058 was awarded to Progenics Pharmaceuticals Inc. by Veterans Integrated Service Network 15 (Veterans Health Administration) on November 1, 2025.
How much is contract 36C25526N0058 worth?
The government has obligated $396,959 on 36C25526N0058.
Is contract 36C25526N0058 an order under another contract?
Yes. 36C25526N0058 is a BPA call under 36F79725D0093-36C25526A0007, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C25526N0058 competed?
The extent of competition for 36C25526N0058 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award